Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.0K
The pathophysiology of pneumonia involves the following steps:
4.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

13
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
13
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

47
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
47
Colonisation of Pathogens01:25

Colonisation of Pathogens

12
Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
12
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

33
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
33

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical severity-dependent virulence of <i>Staphylococcus aureus</i> from human diabetic foot ulcers drives impaired wound healing in a diabetic murine model.

Frontiers in cellular and infection microbiology·2026
Same author

Engineered antibodies bypass bacterial immune evasion to drive complement-mediated protection against lethal infections.

Science translational medicine·2026
Same author

AliC and AliD of nonencapsulated <i>Streptococcus pneumoniae</i> enhance virulence in a <i>Galleria mellonella</i> model of infection by contributing to reactive oxygen species resistance.

Frontiers in cellular and infection microbiology·2025
Same author

Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2.

Nature immunology·2025
Same author

Ultrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2024
Same author

Molecular and structural basis of oligopeptide recognition by the Ami transporter system in pneumococci.

PLoS pathogens·2024

Related Experiment Video

Updated: Mar 23, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

13.3K

Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis.

Lance E Keller1, D Ashley Robinson1, Larry S McDaniel2

  • 1Department of Microbiology and Immunology, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Mbio
|March 24, 2016
PubMed
Summary

Nonencapsulated Streptococcus pneumoniae (NESp) causes disease despite lacking a capsule and is resistant to current vaccines. Further research is needed to develop effective vaccines against both encapsulated and nonencapsulated pneumococcal strains.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Related Experiment Videos

Last Updated: Mar 23, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

13.3K
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

2.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Area of Science:

  • Microbiology
  • Vaccinology
  • Genetics

Background:

  • Current vaccines protect against encapsulated Streptococcus pneumoniae but not nonencapsulated strains (NESp).
  • NESp strains, lacking a capsule, utilize surface proteins for colonization and virulence, challenging previous pathogenesis models.
  • These strains are increasingly prevalent and harbor antibiotic resistance genes, posing a significant public health concern.

Purpose of the Study:

  • To investigate the role of nonencapsulated Streptococcus pneumoniae (NESp) in pneumococcal disease.
  • To understand the genetic basis and epidemiological characteristics of NESp.
  • To highlight the limitations of current vaccines against NESp and advocate for new vaccine development.

Main Methods:

  • Analysis of NESP isolates from carriage and disease cases.
  • Multilocus sequence typing (MLST) to define NESp lineages.
  • Examination of genetic loci, including the capsular polysaccharide (cps) locus and surface protein genes.

Main Results:

  • NESp strains are found in 3-19% of asymptomatic carriers and cause various infections, notably conjunctivitis and otitis media.
  • Classical NESp lineages (ST344, ST448) are linked to conjunctivitis, while sporadic lineages (e.g., ST1106) are associated with other diseases.
  • Sporadic NESp lineages exhibit higher recombination rates, facilitating the acquisition of antibiotic resistance and virulence factors.

Conclusions:

  • Nonencapsulated Streptococcus pneumoniae (NESp) represents a significant and potentially growing challenge in pneumococcal disease.
  • NESp pathogenesis relies on surface proteins, not capsules, and these strains are increasingly problematic due to antibiotic resistance and vaccine evasion.
  • Development of novel vaccines targeting both encapsulated and nonencapsulated pneumococci is crucial for comprehensive disease prevention.